Medical Research
About
The John Curtin School of Medical Research is amongst Australia's leading research institutes and performs fundamental research that tackles real-world health challenges whilst nurturing the next generation of medical researchers.
The institute was established in 1948 as a founding school of the Australian National University. We are renowned for pioneering medical breakthroughs. With a legacy of three Nobel Laureates and a league of exceptional researchers, our focus is collaborative, innovative research tackling diseases that encompass cancer, infectious diseases and neurological conditions using our expertise in neuroscience, genomics, immunology, and cancer discovery science.
Facilities
The Advanced Imaging Precinct includes the Centre for Advanced Microscopy (CAM) and the National Laboratory for X-ray Micro Computed Tomography (CTLab).
We are committed to helping researchers be at the forefront of scientific discovery in the fields of genetics, genomics, and molecular biosciences.
The CHASM Facility offers cutting edge instrumentation and expertise in high dimensional flow cytometry cell analysis, cell sorting, histology, automated immunochemistry, in vivo optical imaging, low dose micro-CT and Spatial Multiomics services.
News
Scientists from all over the world have been racing to understand the fundamentals of Devil Facial Tumour Disease and find a way to stop it. One of them is Yi Ning (Sabrina) Fu, a recent Honours graduate at JCSMR.
Artificial intelligence (AI)-powered protein models combined with genome sequencing technology could help scientists better diagnose and treat genetic diseases.
New research shows how mice process visual information from both eyes when under threat.
ANU spinoff company Ability Optics Pty Ltd is accelerating to revolutionise biotechnology with an aim to speed up early lead drug screening by 100-fold.
New research provides insight into how cells identify and discard faulty molecular machines responsible for RNA splicing.
An immune protein could hold the key to developing new drugs to help fight bowel cancer.